focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCALL.L Regulatory News (CALL)

  • There is currently no data for CALL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Directors and Strategy Update

14 Apr 2011 07:00

RNS Number : 8783E
Zenergy Power PLC
14 April 2011
 

 

14th April 2011

 

 

Zenergy Power plc

("Zenergy" or "the Company")

New Directors & Strategy Update

 

Following the announcement made yesterday, the Board is providing additional background on the new directors and an interim strategy update.

 

The new directors:

 

Simon Cleaver

Simon is an entrepreneur and highly experienced director who has built, developed and sold a number of successful companies in both the private and the public arenas. He has specialist knowledge of acquiring and turning around companies or assets, often under distressed circumstances.

 

Businesses that he has built and sold include Serve Logic plc, Business Serve plc, RDP Ltd and Dalehart Ltd. Prior to setting out on his own, Simon worked in the City for Bailey Shatkin working in the field of derivatives. He was educated in the UK and studied Chemistry at Leicester Polytechnic.

 

David Whelan

David Whelan is the Chief Executive of the Cloverleaf Group, the second largest shareholder in Zenergy. The Cloverleaf Group is a privately held alternative investment group focused primarily on venture capital and private equity investments in healthcare, life sciences and breakthrough technologies. 

 

David is a director of the following Cloverleaf Group portfolio companies: AgaMatrix, Inc; Block Shield Corporation Ltd; Identitas, Inc, MD Datacor, Inc. and was recently appointed Chairman of Medcenter Holdings, Inc. David was also the founding manager of the Group's investment in Zenergy Power Plc. 

 

Prior to joining the Cloverleaf Group, David was Vice President of Corporate Development with the Virgin Group in the US and the UK. David led the development and start up of the largest ever Virgin Group company - Virgin America, a U.S. based low cost airline.

 

David was previously an investment banker in London and Sydney with Goldman Sachs & Company and before that Deutsche Bank. Starting his career at Price Waterhouse in the firm's Corporate Finance division in Sydney, David qualified as a Chartered Accountant of Australia. David has a Bachelor of Laws (Honours) and Bachelor of Commerce from Bond University in Queensland, Australia.

 

Georg Oehm

Georg is one of the founders of Mellinckrodt & Cie, Zug, Switzerland. Prior to this he was MD and Partner in a financial communications boutique in Frankfurt am Main. He was also one of the founders and the first MD of the German CFD Association e.V.

 

Before that Georg worked five years on special restructuring projects following five years at Metallgesellschaft AG in the Corporate Development and M&A department.

 

He finished his PhD in the faculty of economics and social sciences at the University of Kiel, following studies of business economics in Mainz and Kiel. Georg started his professional education with a bank apprenticeship at Dresdner Bank AG in Frankfurt am Main.

 

 

Strategy Update

 

The Company will provide shareholders with a more detailed strategic update in the near future once a detailed review of the Company's operations has been conducted. Meanwhile, the new executive Chairman, Simon Cleaver, comments:

 

 "The changed Board firmly believes that to have sold the Company in its entirety at the current time would not have maximised the potential value of Zenergy. High Temperature Superconductivity (HTS) has the ability to provide a step change in efficiency levels for electronic power distribution networks (grids), electrical metal heating and renewable power generation and Zenergy is almost certainly the global leader in the field.

 

"Whilst we need to get our sleeves rolled up and conduct an immediate review of the Company before we issue any detailed plans, our initial strategy is based on using the Company's specialist IP and knowledge to form joint ventures and strategic alliances to help commercialise Zenergy's products.

 

"We are pleased to have concluded these Board changes. The Board will now be focused on giving the business a new and very clear strategic direction with the aim of restoring shareholder value and working with industry partners to continue developing what the Board believes is a suite of market leading products."

 

 

-Ends-

 

Further information

 

Simon Cleaver, Chairman

Zenergy Power Plc

+ 44 1344 667 347

Stephen Mischler

Matrix Corporate Capital

+ 44 20 3206 7000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAIJMFTMBJBBLB
Date   Source Headline
14th Aug 20197:30 amRNSSchedule 2(G) corrections
14th Aug 20197:00 amRNSAppointment of Nominated Adviser and Sole Broker
16th Jul 20197:00 amRNSTrading Statement
11th Jul 201911:00 amRNSTrading update webinar arrangements
18th Jun 20197:00 amRNSHolding(s) in Company
17th Jun 20193:44 pmRNSHolding(s) in Company
12th Jun 20197:00 amRNSNew CRM Integration
11th Jun 20197:00 amRNSHolding(s) in Company
7th Jun 201910:27 amRNSAdditional Block Admission and Total Voting Rights
4th Jun 20197:00 amRNSContract Win
21st May 20193:23 pmRNSResult of AGM
1st May 20194:34 pmRNSTotal Voting Rights
1st May 20193:49 pmRNSHolding(s) in Company
23rd Apr 20199:31 amRNSHolding(s) in Company
17th Apr 20194:07 pmRNSHolding(s) in Company
16th Apr 20192:06 pmRNSHolding(s) in Company
29th Mar 20197:00 amRNSHolding(s) in Company
27th Mar 20192:05 pmRNSSecond Price Monitoring Extn
27th Mar 20192:00 pmRNSPrice Monitoring Extension
27th Mar 20197:00 amRNSFinal Results
13th Mar 201911:29 amRNSNotice of Results
7th Feb 201912:40 pmRNSHolding(s) in Company
30th Jan 20198:41 amRNSResult of Placing
30th Jan 20197:00 amRNSPlacing
15th Jan 20197:00 amRNSTrading Statement
6th Dec 20187:00 amRNSCapital Markets Day
4th Dec 20185:52 pmRNSHolding(s) in Company
4th Dec 20185:51 pmRNSHolding(s) in Company
4th Dec 20183:42 pmRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSNotification of Trading Statement
30th Nov 201810:09 amRNSBlock Admission return & Total Voting Rights
12th Nov 201810:07 amRNSDirector/PDMR Shareholding
6th Nov 20182:52 pmRNSHolding(s) in Company
31st Oct 201812:00 pmRNSTotal Voting Rights
9th Oct 201812:21 pmRNSDirector/PDMR Shareholding
9th Oct 20187:00 amRNSDirector/PDMR Shareholding
8th Oct 20181:30 pmRNSHolding(s) in Company
8th Oct 201810:47 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSHalf-year Report
10th Sep 20188:51 amRNSNotice of Results and Webinar
10th Sep 20187:00 amRNSNotice of Results and Webinar
31st Aug 20184:23 pmRNSTotal Voting Rights
20th Jul 20187:54 amRNSDirector/PDMR Shareholding
17th Jul 20187:00 amRNSHalf-year trading update
29th Jun 201812:49 pmRNSHolding(s) in Company
30th May 20181:57 pmRNSBlock Admission and Total Voting Rights
17th May 20187:00 amRNSLaunch of New Products
30th Apr 20184:28 pmRNSShare Option Exercise and Issue of Equity
27th Apr 20188:33 amRNSBlock Admission
23rd Apr 20184:47 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.